Advisor Resource Council Purchases New Position in UnitedHealth Group Incorporated (NYSE:UNH)
by Scott Moore · The Cerbat GemAdvisor Resource Council purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,327 shares of the healthcare conglomerate’s stock, valued at approximately $1,162,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Brighton Jones LLC raised its position in UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Union Bancaire Privee UBP SA purchased a new stake in UnitedHealth Group during the fourth quarter valued at approximately $27,233,000. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG raised its holdings in shares of UnitedHealth Group by 3.9% in the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate’s stock worth $133,373,000 after buying an additional 9,872 shares during the period. Finally, Strategic Financial Concepts LLC raised its holdings in shares of UnitedHealth Group by 35.9% in the fourth quarter. Strategic Financial Concepts LLC now owns 594 shares of the healthcare conglomerate’s stock worth $300,000 after buying an additional 157 shares during the period. 87.86% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. increased their price target on UnitedHealth Group from $405.00 to $418.00 and gave the stock an “overweight” rating in a report on Friday. TD Cowen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target on the stock. in a report on Monday, May 19th. Truist Financial reiterated a “buy” rating and issued a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a report on Monday, May 19th. KeyCorp reduced their price objective on UnitedHealth Group from $450.00 to $400.00 and set an “overweight” rating on the stock in a report on Monday, June 2nd. Finally, Wolfe Research reduced their price objective on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating on the stock in a report on Tuesday, May 20th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $427.09.
Read Our Latest Research Report on UnitedHealth Group
Insider Buying and Selling
In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer now owns 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Kristen Gil acquired 3,700 shares of UnitedHealth Group stock in a transaction on Thursday, May 15th. The shares were bought at an average price of $271.17 per share, with a total value of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Insiders bought 109,408 shares of company stock worth $31,607,768 in the last 90 days. Insiders own 0.28% of the company’s stock.
UnitedHealth Group Stock Down 1.7%
Shares of NYSE UNH opened at $302.04 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $273.99 billion, a PE ratio of 12.65, a price-to-earnings-growth ratio of 1.44 and a beta of 0.44. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The stock’s fifty day simple moving average is $359.15 and its two-hundred day simple moving average is $463.79.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. During the same period in the previous year, the business earned $6.91 EPS. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
UnitedHealth Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Investors of record on Monday, June 16th will be paid a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.93%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- What is the MACD Indicator and How to Use it in Your Trading
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Overheated Market? Analysts Watch These Red Flags
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).